Millennium Management LLC Has $21.35 Million Stock Holdings in Chemed Co. (NYSE:CHE)

Millennium Management LLC lifted its stake in shares of Chemed Co. (NYSE:CHE) by 126.5% in the second quarter, Holdings Channel.com reports. The fund owned 39,344 shares of the company’s stock after acquiring an additional 21,974 shares during the quarter. Millennium Management LLC’s holdings in Chemed were worth $21,347,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the stock. Dark Forest Capital Management LP grew its stake in Chemed by 6.1% during the second quarter. Dark Forest Capital Management LP now owns 1,447 shares of the company’s stock worth $785,000 after purchasing an additional 83 shares during the period. Squarepoint Ops LLC boosted its holdings in shares of Chemed by 77.7% during the 2nd quarter. Squarepoint Ops LLC now owns 20,172 shares of the company’s stock worth $10,945,000 after buying an additional 8,819 shares in the last quarter. Bank of Montreal Can grew its position in shares of Chemed by 231.3% during the 2nd quarter. Bank of Montreal Can now owns 9,528 shares of the company’s stock worth $5,233,000 after buying an additional 6,652 shares during the period. Lombard Odier Asset Management Europe Ltd bought a new stake in shares of Chemed in the 2nd quarter valued at $9,534,000. Finally, Evergreen Capital Management LLC bought a new stake in shares of Chemed in the 2nd quarter valued at $7,812,000. 95.85% of the stock is currently owned by institutional investors.

Insider Transactions at Chemed

In other Chemed news, Director George J. Walsh III sold 400 shares of the company’s stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $597.47, for a total value of $238,988.00. Following the completion of the sale, the director now directly owns 3,046 shares of the company’s stock, valued at approximately $1,819,893.62. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, Director Andrea R. Lindell sold 831 shares of the stock in a transaction on Friday, August 16th. The stock was sold at an average price of $571.51, for a total transaction of $474,924.81. Following the completion of the transaction, the director now owns 5,725 shares in the company, valued at approximately $3,271,894.75. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director George J. Walsh III sold 400 shares of the stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $597.47, for a total transaction of $238,988.00. Following the transaction, the director now owns 3,046 shares of the company’s stock, valued at $1,819,893.62. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 9,144 shares of company stock worth $5,264,839 in the last quarter. 3.32% of the stock is currently owned by corporate insiders.

Chemed Stock Down 0.6 %

Shares of NYSE CHE opened at $581.55 on Friday. Chemed Co. has a 12-month low of $497.36 and a 12-month high of $654.62. The firm has a market cap of $8.80 billion, a PE ratio of 31.30, a P/E/G ratio of 2.40 and a beta of 0.44. The company’s fifty day simple moving average is $579.20 and its 200 day simple moving average is $574.47.

Chemed (NYSE:CHE) last issued its earnings results on Wednesday, July 24th. The company reported $5.47 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.59 by ($0.12). Chemed had a return on equity of 29.21% and a net margin of 12.88%. The firm had revenue of $595.88 million during the quarter, compared to the consensus estimate of $599.20 million. During the same quarter in the prior year, the business earned $4.71 earnings per share. Chemed’s revenue for the quarter was up 7.6% on a year-over-year basis. On average, equities analysts predict that Chemed Co. will post 21.77 earnings per share for the current year.

Chemed Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Monday, August 12th were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.34%. This is an increase from Chemed’s previous quarterly dividend of $0.40. The ex-dividend date of this dividend was Monday, August 12th. Chemed’s payout ratio is currently 10.76%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.